Reckitt Benckiser Group (LON:RKT – Get Free Report) was downgraded by analysts at JPMorgan Chase & Co. to a “neutral” rating in a report issued on Friday, MarketBeat reports.
Several other research firms have also commented on RKT. Jefferies Financial Group restated a “hold” rating and issued a GBX 4,400 ($58.02) price objective on shares of Reckitt Benckiser Group in a research report on Monday, July 29th. Berenberg Bank upped their price objective on Reckitt Benckiser Group from GBX 5,100 ($67.26) to GBX 5,200 ($68.57) and gave the stock a “hold” rating in a research report on Wednesday, July 24th.
Get Our Latest Analysis on RKT
Reckitt Benckiser Group Trading Up 0.6 %
Insider Transactions at Reckitt Benckiser Group
In other Reckitt Benckiser Group news, insider Tamara Ingram bought 350 shares of Reckitt Benckiser Group stock in a transaction dated Wednesday, June 5th. The stock was acquired at an average cost of GBX 4,509 ($59.46) per share, with a total value of £15,781.50 ($20,811.68). Corporate insiders own 0.07% of the company’s stock.
Reckitt Benckiser Group Company Profile
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
Further Reading
- Five stocks we like better than Reckitt Benckiser Group
- What is a Death Cross in Stocks?
- Birkenstock’s Sudden Slide—Why It Might Be Your Next Big Win
- What is the Australian Securities Exchange (ASX)
- MarketBeat Week in Review – 8/26 – 8/30
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Why Dell Can Continue Winning in AI and Beyond
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.